ADMA Biologics Inc(ADMA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ADMA ADMA Biologics Inc

盘前交易 07-22 07:34:30 EDT

13.36

+0.31

+2.38%

最高13.42	最低13.04	成交量282.56万
今开13.17	昨收13.05	日振幅2.91%
总市值30.97亿	流通市值30.43亿	总股本2.32亿
成交额3,755万	换手率1.24%	流通股本2.28亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ADMA","market":"US","secType":"STK","nameCN":"ADMA Biologics Inc","latestPrice":13.36,"timestamp":1721419200000,"preClose":13.05,"halted":0,"volume":2825554,"delay":0,"floatShares":227757195,"shares":231809197,"eps":-0.016144,"marketStatus":"盘前交易","marketStatusCode":1,"change":0.31,"latestTime":"07-22 07:34:30 EDT","open":13.17,"high":13.42,"low":13.04,"amount":37547071.994722,"amplitude":0.029119,"askPrice":13.9,"askSize":10,"bidPrice":12.26,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.016144,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721655000000},"adr":0,"adjPreClose":13.36,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":13.4,"preClose":13.36,"latestTime":"19:47 EDT","volume":52584,"amount":703209.6731,"timestamp":1721432855615},"volumeRatio":0.7266743408781544,"impliedVol":0.6401,"impliedVolPercentile":0.168},"requestUrl":"/m/hq/s/ADMA/wiki","defaultTab":"wiki","newsList":[{"id":"2451241016","title":"Adma Biologics Inc盘中异动 早盘股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2451241016","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451241016?lang=zh_cn&edition=full","pubTime":"2024-07-15 23:25","pubTimestamp":1721057104,"startTime":"0","endTime":"0","summary":"北京时间2024年07月15日23时25分，Adma Biologics Inc股票出现波动，股价大幅上涨5.01%。Adma Biologics Inc股票所在的生物技术行业中，整体涨幅为0.15%。Adma Biologics Inc公司简介：ADMA Biologics Inc是一家端到端的商业生物制药公司，致力于生产、营销和开发特殊的血浆衍生生物制剂，用于治疗有感染风险的免疫缺陷患者和其他有某些传染病风险的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715232504af92679d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715232504af92679d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADMA","BK4139"],"gpt_icon":0},{"id":"2436189428","title":"Adma Biologics Inc2024财年第一财季实现净利润17.81百万美元，同比增加362.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2436189428","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2436189428?lang=zh_cn&edition=full","pubTime":"2024-05-19 00:08","pubTimestamp":1716048507,"startTime":"0","endTime":"0","summary":"3月31日，Adma Biologics Inc公布财报，公告显示公司2024财年第一财季净利润为17.81百万美元，同比增加362.30%；其中营业收入为81.88百万美元，同比增加43.88%，每股基本收益为0.08美元。从资产负债表来看，Adma Biologics Inc总负债1.97亿美元，其中短期债务1.09百万美元，资产负债比为1.79，流动比率为0.06。机构评级：截至2024年3月31日，当前有4家机构对Adma Biologics Inc目标价做出预测，其中目标均价为10.50美元，其中最低目标价为10.00美元，最高目标价为12.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051900083587780486&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051900083587780486&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADMA"],"gpt_icon":0},{"id":"2434314851","title":"Adma Biologics Inc盘中异动 快速上涨17.60%报8.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2434314851","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434314851?lang=zh_cn&edition=full","pubTime":"2024-05-10 21:30","pubTimestamp":1715347826,"startTime":"0","endTime":"0","summary":"北京时间2024年05月10日21时30分，Adma Biologics Inc股票出现波动，股价急速拉升17.60%。Adma Biologics Inc股票所在的生物技术行业中，整体涨幅为0.97%。Adma Biologics Inc公司简介：ADMA Biologics Inc是一家端到端的商业生物制药公司，致力于生产、营销和开发特殊的血浆衍生生物制剂，用于治疗有感染风险的免疫缺陷患者和其他有某些传染病风险的患者。该信息摘要如下：瑞穗银行：维持ADMA Biologics评级，由买入调整至买入评级, 目标价由10.00美元调整至12.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051021302687e8718c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051021302687e8718c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADMA","BK4139"],"gpt_icon":0},{"id":"2434285311","title":"瑞穗银行：维持ADMA Biologics(ADMA.US)评级，由买入调整至买入评级, 目标价由10.00美元调整至12.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2434285311","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434285311?lang=zh_cn&edition=full","pubTime":"2024-05-10 20:16","pubTimestamp":1715343392,"startTime":"0","endTime":"0","summary":"瑞穗银行：维持ADMA Biologics(ADMA.US)评级，由买入调整至买入评级, 目标价由10.00美元调整至12.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405102016378750bd7b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405102016378750bd7b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADMA"],"gpt_icon":0},{"id":"2429115097","title":"Adma Biologics Inc盘中异动 股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429115097","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2429115097?lang=zh_cn&edition=full","pubTime":"2024-04-23 22:41","pubTimestamp":1713883308,"startTime":"0","endTime":"0","summary":"北京时间2024年04月23日22时41分，Adma Biologics Inc股票出现波动，股价快速上涨5.00%。截至发稿，该股报6.51美元/股，成交量68.3186万股，换手率0.29%，振幅4.52%。Adma Biologics Inc股票所在的生物技术行业中，整体涨幅为1.55%。Adma Biologics Inc公司简介：ADMA Biologics Inc是一家端到端的商业生物制药公司，致力于生产、营销和开发特殊的血浆衍生生物制剂，用于治疗有感染风险的免疫缺陷患者和其他有某些传染病风险的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232241497a54f198&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232241497a54f198&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ADMA"],"gpt_icon":0},{"id":"2417245245","title":"Adma Biologics Inc盘中异动 下午盘快速拉升5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2417245245","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2417245245?lang=zh_cn&edition=full","pubTime":"2024-03-07 02:53","pubTimestamp":1709751235,"startTime":"0","endTime":"0","summary":"北京时间2024年03月07日02时53分，Adma Biologics Inc股票出现异动，股价快速拉升5.00%。截至发稿，该股报6.09美元/股，成交量206.487万股，换手率0.90%，振幅6.03%。Adma Biologics Inc股票所在的生物技术行业中，整体涨幅为0.09%。Adma Biologics Inc公司简介：ADMA Biologics Inc是一家端到端的商业生物制药公司，致力于生产、销售和开发特种血浆来源的生物制品，用于治疗有感染风险的免疫缺陷患者和其他有某些传染病风险的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403070253557a4a2841&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403070253557a4a2841&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADMA","BK4139"],"gpt_icon":0},{"id":"2417120677","title":"Adma Biologics Inc盘中异动 股价大涨5.07%报5.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2417120677","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2417120677?lang=zh_cn&edition=full","pubTime":"2024-03-05 01:54","pubTimestamp":1709574863,"startTime":"0","endTime":"0","summary":"北京时间2024年03月05日01时54分，Adma Biologics Inc股票出现波动，股价大幅拉升5.07%。截至发稿，该股报5.80美元/股，成交量122.978万股，换手率0.54%，振幅5.07%。Adma Biologics Inc股票所在的生物技术行业中，整体跌幅为0.08%。Adma Biologics Inc公司简介：ADMA Biologics Inc是一家端到端的商业生物制药公司，致力于生产、销售和开发特种血浆来源的生物制品，用于治疗有感染风险的免疫缺陷患者和其他有某些传染病风险的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240305015424861db0d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240305015424861db0d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ADMA","OCEA"],"gpt_icon":0},{"id":"2416901367","title":"Adma Biologics Inc2023财年实现净利润-28.24百万美元，同比增加57.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2416901367","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2416901367?lang=zh_cn&edition=full","pubTime":"2024-03-04 00:27","pubTimestamp":1709483246,"startTime":"0","endTime":"0","summary":"12月31日，Adma Biologics Inc公布财报，公告显示公司2023财年净利润为-28.24百万美元，同比增加57.15%；其中营业收入为2.58亿美元，同比增加67.53%，每股基本收益为-0.13美元。从资产负债表来看，Adma Biologics Inc总负债1.94亿美元，其中短期债务1.05百万美元，资产负债比为1.70，流动比率为0.06。机构评级：截至2023年12月31日，当前有4家机构对Adma Biologics Inc目标价做出预测，其中目标均价为8.00美元，其中最低目标价为6.00美元，最高目标价为10.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403040027308afdda47&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403040027308afdda47&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADMA"],"gpt_icon":0},{"id":"2415523844","title":"Adma Biologics Inc盘中异动 快速拉升5.02%报5.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2415523844","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2415523844?lang=zh_cn&edition=full","pubTime":"2024-02-29 22:55","pubTimestamp":1709218516,"startTime":"0","endTime":"0","summary":"北京时间2024年02月29日22时55分，Adma Biologics Inc股票出现波动，股价急速上涨5.02%。Adma Biologics Inc股票所在的生物技术行业中，整体跌幅为1.26%。Adma Biologics Inc公司简介：ADMA Biologics Inc是一家端到端的商业生物制药公司，致力于生产、销售和开发特种血浆来源的生物制品，用于治疗有感染风险的免疫缺陷患者和其他有某些传染病风险的患者。消息层面，截至22时55分，《Earnings Call Summary | ADMA Biologics Q4 2023 Earnings Conference》资讯为影响Adma Biologics Inc的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240229225518861da32e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240229225518861da32e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADMA","BK4139"],"gpt_icon":0},{"id":"2415343245","title":"ADMA 生物制品公司公布截至 12 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2415343245","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2415343245?lang=zh_cn&edition=full","pubTime":"2024-02-29 09:06","pubTimestamp":1709168807,"startTime":"0","endTime":"0","summary":"   * ADMA Biologics Inc   报告，截至12月底的季度调整后每股亏损8美分，低于去年同期的每股收益-6美分。四位分析师对该季度的平均预期是每股收益 3 美分。华尔街预期为每股收益 1 美分至 4 美分。* 营收同比增长 47.9%，达到 7390 万美元；分析师预期为 7215 万美元。* ADMA Biologics Inc公布的本季度每股收益为亏损8美分。* 该公司当季亏损1764万美元。* ADMA Biologics Inc 的股价本季度上涨了 22.1%。华尔街对 ADMA Biologics Inc 的 12 个月目标价中位数为 6.25 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ADMA"],"gpt_icon":0},{"id":"2411360905","title":"Adma Biologics Inc盘中异动 股价大跌5.04%报5.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2411360905","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2411360905?lang=zh_cn&edition=full","pubTime":"2024-02-14 01:36","pubTimestamp":1707845788,"startTime":"0","endTime":"0","summary":"北京时间2024年02月14日01时36分，Adma Biologics Inc股票出现异动，股价大幅下跌5.04%。截至发稿，该股报5.19美元/股，成交量62.4279万股，换手率0.28%，振幅2.93%。Adma Biologics Inc股票所在的生物技术行业中，整体跌幅为0.60%。Adma Biologics Inc公司简介：ADMA Biologics Inc是一家端到端的商业生物制药公司，致力于生产、销售和开发特种血浆来源的生物制品，用于治疗有感染风险的免疫缺陷患者和其他有某些传染病风险的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402140136297a437cd8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402140136297a437cd8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ADMA"],"gpt_icon":0},{"id":"2407817524","title":"Adma Biologics Inc盘中异动 股价大涨5.11%报5.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2407817524","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2407817524?lang=zh_cn&edition=full","pubTime":"2024-01-30 05:01","pubTimestamp":1706562061,"startTime":"0","endTime":"0","summary":"北京时间2024年01月30日05时01分，Adma Biologics Inc股票出现波动，股价大幅上涨5.11%。Adma Biologics Inc股票所在的生物技术行业中，整体涨幅为1.34%。其相关个股中，Fibrogen Inc、Palisade Bio Inc、Neximmune Inc涨幅较大，Revelation Biosciences Inc、Palisade Bio Inc、Panbela Therapeutics Inc较为活跃，换手率分别为2554.72%、1448.86%、1447.85%，振幅较大的相关个股有Revelation Biosciences Inc、Neximmune Inc、Palisade Bio Inc，振幅分别为131.36%、112.34%、107.69%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401300501027a3f5908&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401300501027a3f5908&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ADMA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.admabiologics.com","stockEarnings":[{"period":"1week","weight":0.0454},{"period":"1month","weight":0.258},{"period":"3month","weight":1.1308},{"period":"6month","weight":1.6667},{"period":"1year","weight":2.5532},{"period":"ytd","weight":1.9558}],"compareEarnings":[{"period":"1week","weight":-0.0196},{"period":"1month","weight":0.0009},{"period":"3month","weight":0.1087},{"period":"6month","weight":0.138},{"period":"1year","weight":0.2141},{"period":"ytd","weight":0.155}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"ADMA Biologics, Inc.于2004年6月24日在新泽西州注册成立。该公司是一家端到端的商业生物制药公司，致力于制造、营销和开发专门的生物制剂，用于治疗有感染风险的免疫缺陷患者和其他有特定传染病风险的人。该公司的目标患者群体包括患有潜在免疫缺陷疾病或可能因医疗原因而受到免疫抑制的免疫功能受损个体。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.036203},{"month":2,"riseRate":0.5,"avgChangeRate":-0.013938},{"month":3,"riseRate":0.6,"avgChangeRate":0.097898},{"month":4,"riseRate":0.6,"avgChangeRate":0.007327},{"month":5,"riseRate":0.7,"avgChangeRate":0.076004},{"month":6,"riseRate":0.2,"avgChangeRate":-0.053782},{"month":7,"riseRate":0.7,"avgChangeRate":0.122696},{"month":8,"riseRate":0.222222,"avgChangeRate":-0.032938},{"month":9,"riseRate":0.111111,"avgChangeRate":-0.039779},{"month":10,"riseRate":0.444444,"avgChangeRate":-0.036554},{"month":11,"riseRate":0.555556,"avgChangeRate":0.062096},{"month":12,"riseRate":0.4,"avgChangeRate":-0.05303}],"exchange":"NASDAQ","name":"ADMA Biologics Inc","nameEN":"ADMA Biologics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ADMA Biologics Inc(ADMA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供ADMA Biologics Inc(ADMA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"ADMA Biologics Inc,ADMA,ADMA Biologics Inc股票,ADMA Biologics Inc股票老虎,ADMA Biologics Inc股票老虎国际,ADMA Biologics Inc行情,ADMA Biologics Inc股票行情,ADMA Biologics Inc股价,ADMA Biologics Inc股市,ADMA Biologics Inc股票价格,ADMA Biologics Inc股票交易,ADMA Biologics Inc股票购买,ADMA Biologics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ADMA Biologics Inc(ADMA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供ADMA Biologics Inc(ADMA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}